483
Societal CDMO Gainesville, LLCFDA 483 - Societal CDMO Gainesville, LLC - August 12, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Recro Gainesville LLC, a drug manufacturer in Gainesville, GA, revealed significant deficiencies in laboratory record-keeping and the quality control unit's investigation processes. Specifically, the firm failed to maintain complete analytical data and adequately investigate non-conformances and out-of-specification results. These issues indicate a lack of robust quality assurance and data integrity practices.
Open in Dashboard
ID · 44334b9e-433a-42ea-8b7b-ff4347c8ee71